Veterinary Blog
Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates
Featuring
Veterinary Targeted Therapies in the Time of COVID-19, Part 1
Dr. London is a global leader in veterinary targeted therapies. She discusses potential risks to veterinary staff, the value of targeted therapy in times of constrained PPE resources, and the effects of COVID-19 on research activity.
Webinars
Understanding Sequencing Methodology
Nucleic acids are the “building blocks” of life; they determine all inherited characteristics in life and direct the process of protein synthesis. These important biomolecules create, encode and store information in all cells.
How Dogs with Cancer Can Benefit From DNA Sequencing
Next-generation sequencing (NGS) technology gives veterinarians the ability to generate a tremendous amount of comprehensive data and this information allows for a much deeper understanding of cancer pathogenesis and behavior.
Choosing Love and Compassion
This is a big and stressful moment for the country. We want to take a moment to acknowledge that for all of us.
Reflecting on 2020
At FidoCure®, we were fortunate to make progress on our mission to advance canine cancer treatment, despite the challenges of 2020.
Introducing the New Veterinarian Portal Dashboard
Not only are we working hard to expand our canine cancer toolbox, we’re continually working to improve the user experience for veterinarians.
Featuring
Unique Perspective: Cancer Biologist & Pet Cancer Parent
When your dog has cancer and you're also a world-renowned cancer researcher, your interactions with veterinary oncologists are a little different.
Introducing Olaparib to the FidoCure® Veterinary Oncology Toolbox
Another exciting addition to the FidoCure® oncology toolbox: Olaparib as a new targeted therapy.
Safety and Toxicity of Small Molecule Inhibitors in Dogs with Spontaneously Occurring Malignancies — The Use of Real World Data
The VCS Virtual Conference was held from October 15 - 17, 2020. We had the honor of presenting our abstract during the event.
Introducing Palbociclib: A New Targeted Therapy
We are thrilled to announce a new targeted therapy, Palbociclib, as part of the FidoCure® oncology toolbox.
ProductFeaturing
Great Danes to Grandads: Comparative Cancer and Aging Research
Dr. Ehrhart shares insight from her current work in comparative aging research and highlights its intersection with cancer and musculoskeletal research in veterinary medicine.
Webinars
